List of Tables
Table 1. Opioids Agonist Drugs Market Trends
Table 2. Opioids Agonist Drugs Market Drivers & Opportunity
Table 3. Opioids Agonist Drugs Market Challenges
Table 4. Opioids Agonist Drugs Market Restraints
Table 5. Global Opioids Agonist Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Opioids Agonist Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Opioids Agonist Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Opioids Agonist Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Opioids Agonist Drugs
Table 10. Global Opioids Agonist Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Opioids Agonist Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Opioids Agonist Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Opioids Agonist Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Opioids Agonist Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Opioids Agonist Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Opioids Agonist Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Opioids Agonist Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Opioids Agonist Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Opioids Agonist Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Opioids Agonist Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Opioids Agonist Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Opioids Agonist Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Opioids Agonist Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Opioids Agonist Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Opioids Agonist Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Opioids Agonist Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Opioids Agonist Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Opioids Agonist Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Purdue Pharma Basic Information List
Table 32. Purdue Pharma Description and Business Overview
Table 33. Purdue Pharma Opioids Agonist Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Opioids Agonist Drugs Business of Purdue Pharma (2019-2024)
Table 35. Purdue Pharma Recent Developments
Table 36. Titan pharmaceuticals Basic Information List
Table 37. Titan pharmaceuticals Description and Business Overview
Table 38. Titan pharmaceuticals Opioids Agonist Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Opioids Agonist Drugs Business of Titan pharmaceuticals (2019-2024)
Table 40. Titan pharmaceuticals Recent Developments
Table 41. Boehringer Ingelheim Basic Information List
Table 42. Boehringer Ingelheim Description and Business Overview
Table 43. Boehringer Ingelheim Opioids Agonist Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Opioids Agonist Drugs Business of Boehringer Ingelheim (2019-2024)
Table 45. Boehringer Ingelheim Recent Developments
Table 46. Janssen Pharmaceuticals, Inc Basic Information List
Table 47. Janssen Pharmaceuticals, Inc Description and Business Overview
Table 48. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Opioids Agonist Drugs Business of Janssen Pharmaceuticals, Inc (2019-2024)
Table 50. Janssen Pharmaceuticals, Inc Recent Developments
Table 51. Sanofi Basic Information List
Table 52. Sanofi Description and Business Overview
Table 53. Sanofi Opioids Agonist Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Opioids Agonist Drugs Business of Sanofi (2019-2024)
Table 55. Sanofi Recent Developments
Table 56. Sun Pharmaceuticals Basic Information List
Table 57. Sun Pharmaceuticals Description and Business Overview
Table 58. Sun Pharmaceuticals Opioids Agonist Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Opioids Agonist Drugs Business of Sun Pharmaceuticals (2019-2024)
Table 60. Sun Pharmaceuticals Recent Developments
Table 61. Mallinckrodt Pharmaceuticals Basic Information List
Table 62. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 63. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Opioids Agonist Drugs Business of Mallinckrodt Pharmaceuticals (2019-2024)
Table 65. Mallinckrodt Pharmaceuticals Recent Developments
Table 66. Egalet Corporation Basic Information List
Table 67. Egalet Corporation Description and Business Overview
Table 68. Egalet Corporation Opioids Agonist Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Opioids Agonist Drugs Business of Egalet Corporation (2019-2024)
Table 70. Egalet Corporation Recent Developments
Table 71. Endo Pharmaceuticals Inc. Basic Information List
Table 72. Endo Pharmaceuticals Inc. Description and Business Overview
Table 73. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Opioids Agonist Drugs Business of Endo Pharmaceuticals Inc. (2019-2024)
Table 75. Endo Pharmaceuticals Inc. Recent Developments
Table 76. Allergan, Plc Basic Information List
Table 77. Allergan, Plc Description and Business Overview
Table 78. Allergan, Plc Opioids Agonist Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Opioids Agonist Drugs Business of Allergan, Plc (2019-2024)
Table 80. Allergan, Plc Recent Developments
Table 81. Pfizer Inc Basic Information List
Table 82. Pfizer Inc Description and Business Overview
Table 83. Pfizer Inc Opioids Agonist Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Opioids Agonist Drugs Business of Pfizer Inc (2019-2024)
Table 85. Pfizer Inc Recent Developments
Table 86. Johnson & Johnson Services, Inc. Basic Information List
Table 87. Johnson & Johnson Services, Inc. Description and Business Overview
Table 88. Johnson & Johnson Services, Inc. Opioids Agonist Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Opioids Agonist Drugs Business of Johnson & Johnson Services, Inc. (2019-2024)
Table 90. Johnson & Johnson Services, Inc. Recent Developments
Table 91. Hikma Pharmaceuticals PLC Basic Information List
Table 92. Hikma Pharmaceuticals PLC Description and Business Overview
Table 93. Hikma Pharmaceuticals PLC Opioids Agonist Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Opioids Agonist Drugs Business of Hikma Pharmaceuticals PLC (2019-2024)
Table 95. Hikma Pharmaceuticals PLC Recent Developments
Table 96. Grünenthal Basic Information List
Table 97. Grünenthal Description and Business Overview
Table 98. Grünenthal Opioids Agonist Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Opioids Agonist Drugs Business of Grünenthal (2019-2024)
Table 100. Grünenthal Recent Developments
Table 101. AbbVie Inc. Basic Information List
Table 102. AbbVie Inc. Description and Business Overview
Table 103. AbbVie Inc. Opioids Agonist Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Opioids Agonist Drugs Business of AbbVie Inc. (2019-2024)
Table 105. AbbVie Inc. Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Opioids Agonist Drugs Downstream Customers
Table 109. Opioids Agonist Drugs Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Opioids Agonist Drugs Product Picture
Figure 2. Global Opioids Agonist Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Opioids Agonist Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Opioids Agonist Drugs Report Years Considered
Figure 5. Global Opioids Agonist Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Agonist Drugs Revenue in 2023
Figure 7. Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Codeine Picture
Figure 9. Fentanyl Picture
Figure 10. Meperidine Picture
Figure 11. Methadone Picture
Figure 12. Morphine Picture
Figure 13. Hydrocodone Picture
Figure 14. Global Opioids Agonist Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Opioids Agonist Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Pain Management
Figure 17. Product Picture of Cough Treatment
Figure 18. Product Picture of Diarrhea Treatment
Figure 19. Global Opioids Agonist Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Opioids Agonist Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Opioids Agonist Drugs Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Opioids Agonist Drugs Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Opioids Agonist Drugs Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Opioids Agonist Drugs Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Opioids Agonist Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Opioids Agonist Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Opioids Agonist Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Opioids Agonist Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Opioids Agonist Drugs Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Opioids Agonist Drugs Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Opioids Agonist Drugs Sales Value (%), (2019-2030)
Figure 32. United States Opioids Agonist Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Opioids Agonist Drugs Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Opioids Agonist Drugs Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Opioids Agonist Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Opioids Agonist Drugs Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Opioids Agonist Drugs Sales Value by Application (%), 2023 VS 2030
Figure 38. China Opioids Agonist Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Opioids Agonist Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. China Opioids Agonist Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Opioids Agonist Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Opioids Agonist Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Opioids Agonist Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Opioids Agonist Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Opioids Agonist Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Opioids Agonist Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Opioids Agonist Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Opioids Agonist Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Opioids Agonist Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. India Opioids Agonist Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Opioids Agonist Drugs Sales Value by Type (%), 2023 VS 2030
Figure 52. India Opioids Agonist Drugs Sales Value by Application (%), 2023 VS 2030
Figure 53. Opioids Agonist Drugs Industrial Chain
Figure 54. Opioids Agonist Drugs Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
